Trevo Pro Retrieval System Offers New Clot Removal Technology for Ischemic Stroke
Stryker Neurovascular’s Trevo Pro Retriever is indicated for the removal of blood clots. It uses Stentriever technology to optimized clot integration and retrieval in patients experiencing acute ischemic stroke.
The device demonstrated strong clinical results in the TREVO 2 clinical trial presented at the 2012 European Stroke Conference in May. This technology demonstrated the highest rate of revascularization in a randomized embolectomy stroke device trial, and achieved significantly better post-procedure revascularization than the Merci Retriever (92 percent in the Trevo Retriever arm compared to 76.7 percent in the Merci Retriever arm). Other measures of performance also strongly favored the Trevo Pro Retriever, including improvement in the National Institutes of Health Stroke Scale (NIHSS) score, excellent composite safety endpoints and shorter hospital stays.
The U.S. Food and Drug Administration (FDA) granted 510(k) market clearance for the device in August 2012.
For more information: www.stryker.com